Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin in Alternating Hemiplegia of Childhood
NCT02408354Phase 2Completed
- Sponsor
- Inserm
- Start
- Mar 2015
- Primary completion
- Apr 2017
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triheptanoin in alternating hemiplegia of childhood (AHC), sponsored by Inserm. Started Mar 2015; status: completed.
02
Drugs
triheptanoin
03
Conditions
alternating hemiplegia of childhood (AHC)
Beyond the preview
Go deeper on NCT02408354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408354.